This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sobraquès, M.
Right arrow Articles by Raoult, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sobraquès, M.
Right arrow Articles by Raoult, D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 1999, p. 2090-2092, Vol. 43, No. 8
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

In Vitro Susceptibilities of Four Bartonella bacilliformis Strains to 30 Antibiotic Compounds

Mireille Sobraquès, Max Maurin, Richard J. Birtles, and Didier Raoult*

Unité des Rickettsies, CNRS UPRES A 6020, Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex 05, France

Received 22 April 1999/Accepted 28 May 1999

We have evaluated for the first time in vitro antibiotic susceptibilities of four human strains of Bartonella bacilliformis, the agent of Carrion's disease. Our results show that B. bacilliformis, like other Bartonella species, is highly susceptible to antibiotics, including most beta-lactams, aminoglycosides, chloramphenicol, rifampin, macrolides, tetracyclines, cotrimoxazole, and fluoroquinolones.


* Corresponding author. Mailing address: Unité des Rickettsies, CNRS UPRES A 6020, Faculté de Médecine, Université de la Méditerranée, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 05, France. Phone: (33) 4 91 38 55 17. Fax: (33) 4 91 83 03 90. E-mail: Didier.Raoult{at}medecine.univ-mrs.fr.


Antimicrobial Agents and Chemotherapy, August 1999, p. 2090-2092, Vol. 43, No. 8
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Dorbecker, C., Sander, A., Oberle, K., Schulin-Casonato, T. (2006). In vitro susceptibility of Bartonella species to 17 antimicrobial compounds: comparison of Etest and agar dilution. J Antimicrob Chemother 58: 784-788 [Abstract] [Full Text]  
  • HENRIQUEZ, C., HINOJOSA, J. C., VENTOSILLA, P., INFANTE, B., MERELLO, J., MALLQUI, V., VERASTEGUI, M., MAGUINA, C. (2004). REPORT OF AN UNUSUAL CASE OF PERSISTENT BACTEREMIA BY BARTONELLA BACILLIFORMIS IN A SPLENECTOMIZED PATIENT. Am J Trop Med Hyg 71: 53-55 [Abstract] [Full Text]  
  • Rolain, J. M., Brouqui, P., Koehler, J. E., Maguina, C., Dolan, M. J., Raoult, D. (2004). Recommendations for Treatment of Human Infections Caused by Bartonella Species. Antimicrob. Agents Chemother. 48: 1921-1933 [Full Text]  
  • Minnick, M. F., Wilson, Z. R., Smitherman, L. S., Samuels, D. S. (2003). gyrA Mutations in Ciprofloxacin-Resistant Bartonella bacilliformis Strains Obtained In Vitro. Antimicrob. Agents Chemother. 47: 383-386 [Abstract] [Full Text]  
  • Jacomo, V., Kelly, P. J., Raoult, D. (2002). Natural History of Bartonella Infections (an Exception to Koch's Postulate). CVI 9: 8-18 [Full Text]  
  • Maurin, M., Raoult, D. (2001). Use of Aminoglycosides in Treatment of Infections Due to Intracellular Bacteria. Antimicrob. Agents Chemother. 45: 2977-2986 [Full Text]  
  • Rolain, J.-M., Maurin, M., Bryskier, A., Raoult, D. (2000). In Vitro Activities of Telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis. Antimicrob. Agents Chemother. 44: 1391-1393 [Abstract] [Full Text]